Related Experiment Video
Updated: Jul 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Diagnostic monitoring strategies in heart failure management
Jonathan P Piccini1, Patrick Hranitzky
1Duke University Medical Center, Durham, NC 27710, USA.
Insights
Device-based monitoring can help predict acute decompensated heart failure (ADHF) events. This approach may reduce hospitalizations and healthcare costs for heart failure patients.
Area of Science:
- Cardiology
- Biomedical Engineering
- Health Economics
Background:
- Heart failure (HF) impacts millions, incurring significant healthcare costs, largely due to acute decompensated heart failure (ADHF) hospitalizations.
- Current methods for anticipating and managing ADHF are limited.
- The expanding use of implantable devices in HF management necessitates exploring their diagnostic potential.
Purpose of the Study:
- To review the evidence supporting diagnostic monitoring in heart failure.
- To emphasize the role of device-based monitoring strategies for early detection of decompensation.
Main Methods:
- Literature review of studies on diagnostic monitoring in heart failure.
- Focus on implantable device data for predicting ADHF events.
- Analysis of cost-effectiveness of monitoring strategies.
Main Results:
- Diagnostic monitoring, particularly using implantable devices, shows promise in identifying patients at risk for ADHF.
- Early detection can potentially lead to timely interventions, preventing severe decompensation.
- Device-based monitoring may reduce hospital admissions and associated healthcare expenditures.
Conclusions:
- Implantable devices offer a platform for continuous diagnostic monitoring in heart failure patients.
- Device-based monitoring strategies hold significant potential for proactive management of heart failure and reducing healthcare costs.
Abstract:
Heart failure affects 5 million Americans and is associated with a tremendous economic burden, leading to 26.7 billion dollars in health care expenditures each year (American Heart Association, American Stroke Association. Heart disease and stroke statistics--2004 update. Available at http://www.americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf. Accessed May 4, 2006). Half of these expenditures (nearly $14 billion) are for costly hospital admissions for acute decompensated heart failure. Despite the ubiquity and frequency of acute decompensated heart failure, we have few available techniques to anticipate and correct decompensation. With the advent of the implantable cardioverter defibrillator for the prevention of sudden cardiac death and biventricular pacing for dyssynchrony in heart failure (HF) refractory to medical treatment, indications for implantable devices are expanding in the HF population. Therefore, device-based diagnostic monitoring strategies have the potential to identify patients at risk for decompensation and decrease costly health care uses. The purpose of this review will be to highlight the evidence for diagnostic monitoring in HF, with special emphasis on device-based diagnostic monitoring.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy II: Dilated Cardiomyopathy
